Showing 5,601 - 5,620 results of 63,539 for search '(( 50 ((mean decrease) OR (((nn decrease) OR (a decrease)))) ) OR ( 2 e decrease ))', query time: 0.98s Refine Results
  1. 5601
  2. 5602
  3. 5603
  4. 5604
  5. 5605
  6. 5606

    Prostaglandin-E2 Mediated Increase in Calcium and Phosphate Excretion in a Mouse Model of Distal Nephron Salt Wasting by Manoocher Soleimani (486415)

    Published 2016
    “…Confirmatory studies revealed decreases in the expression levels of sodium phosphate transporter-2 isoforms a and c, increases in the expression of cytochrome p450 family 4a isotypes 12 a and b, as well as prostaglandin E synthase 1, and cyclooxygenases 1 and 2. …”
  7. 5607
  8. 5608

    Table_2_Anti-Inflammatory Properties of Chemical Probes in Human Whole Blood: Focus on Prostaglandin E2 Production.docx by Filip Bergqvist (3185640)

    Published 2020
    “…These findings were validated by concentration–response experiment in two donors. Moreover, the tested MEK inhibitors decreased thromboxane B<sub>2</sub> (TXB<sub>2</sub>) production and IL-8 secretion. …”
  9. 5609

    Expression of E-Cadherin, N-Cadherin, γ, β and α-Catenins in response to glucose for 24 by Sirin A. I. Adham (662525)

    Published 2014
    “…However, MDA-MB-231P and its two variant cell lines did not express detectable E-cadherin message or protein (right); (B) Representative blots (left) and quantification (right) shows that MDA-MB-231P and MDA-MB-231BO cells expressed higher levels of N-cadherin compared with the MDA-MB-231BR cells, and that N-cadherin in the former cells was significantly reduced under hypoglycemia. γ, β and α-Catenins were all reduced under hypoglycemic conditions and their expression was significantly decreased in the two MDA-MB-231 variant cells only. …”
  10. 5610

    DYRK2 Negatively Regulates Cardiomyocyte Growth by Mediating Repressor Function of GSK-3β on eIF2Bε by Celine S. Weiss (453817)

    Published 2013
    “…</p><p>Methods</p><p>Two transgenic mouse lines were generated with cardiac restricted overexpression of eIF2Bε or its mutant eIF2Bε-eIFS<sup>535</sup>A, which cannot be inactivated by phosphorylation through GSK-3β.…”
  11. 5611
  12. 5612
  13. 5613

    Image_2_Augmenting E Protein Activity Impairs cDC2 Differentiation at the Pre-cDC Stage.tif by Sandra Bajana (9870830)

    Published 2020
    “…We expressed an E protein mutant, ET2, which dimerizes with endogenous E proteins to overcome inhibition by ID proteins and activate the transcription of E protein targets. …”
  14. 5614
  15. 5615

    Minimal data set. by Pornpan Chalermkitpanit (22110121)

    Published 2025
    “…This study defined a favorable response as a pain reduction of more than 50% at the 2-week follow-up. …”
  16. 5616

    Supplementary results_detailed. by Pornpan Chalermkitpanit (22110121)

    Published 2025
    “…This study defined a favorable response as a pain reduction of more than 50% at the 2-week follow-up. …”
  17. 5617

    Table_1_Decreased synaptic vesicle glycoprotein 2A binding in a rodent model of familial Alzheimer's disease detected by [18F]SDM-16.DOCX by Chao Zheng (728465)

    Published 2023
    “…In this study, we tested [<sup>18</sup>F]SDM-16, a novel metabolically stable SV2A PET imaging probe, in the transgenic APPswe/PS1dE9 (APP/PS1) mouse model of AD and age-matched wild-type (WT) mice at 12 months of age.…”
  18. 5618
  19. 5619

    The Strong <i>In Vivo</i> Anti-Tumor Effect of the UIC2 Monoclonal Antibody Is the Combined Result of Pgp Inhibition and Antibody Dependent Cell-Mediated Cytotoxicity by Gábor Szalóki (631712)

    Published 2014
    “…The combined addition of UIC2 and 10 times lower concentrations of CsA than what is necessary for Pgp inhibition when the modulator is applied alone, decreased the EC<sub>50</sub> of doxorubicin (DOX) in KB-V1 (Pgp<sup>+</sup>) cells <i>in vitro</i> almost to the level of KB-3-1 (Pgp<sup>-</sup>) cells. …”
  20. 5620